Private Equity
Ipsen has agreed to acquire Clementia Pharmaceuticals (Nasdaq: CMTA), a Montréal-based developer of treatments for people with ultra-rare bone disorders and other diseases. Ipsen agreed to pay US$25 per share in cash upfront plus deferred payments, bringing the total consideration to US$1.31 billion ($1.73 billion). Ipsen, a Paris-based specialty biopharmaceutical group, said the purchase of Clementia's drug candidate palovarotene and other assets will boost its rare disease portfolio. Founded in 2010 by CEO Clarissa Desjardins, Clementia was venture-capital-backed before going public in 2017, raising $174 million. Several investors, including BDC Capital, New Enterprise Associates and OrbiMed Advisors, continue to hold stakes in the company.
9 min read · 25 February 2019
Atlanta-based Sideqik, provider of an influencer marketing and social engagement platform, announced it has raised $5 million in a Series A round. Jackson Square Ventures led the round with participation from Fuqua Capital, Tom Noonan (founder of Internet Security Systems and director for ICE/NYSE and Manhattan Associates), as well as from lead pre-seed investors Bee Partners and Bonfire Ventures.
1 min read · 25 February 2019
Szent, a beverage startup, has raised $2.2 million in funding. Ex-FirstMark Capital co-chairman Gerald Poch led the investor group.
2 min read · 22 February 2019
Zoba, a spatial analytics company, has raised $3 million in seed funding, according to a Medium blog post. CRV led the round with participation from Founder Collective, Kaggle’s Anthony Goldbloom, Matt Brezina and Mark Cuban.
1 min read · 22 February 2019
Oakland, California-based Back to the Roots, an organic food and gardening company, has secured $3 million in Series C funding. Central Garden & Pet led the round with participation from Blue Scorpion Investments.
1 min read · 22 February 2019
NuChem Therapeutics Inc, a Montréal-based drug discovery and development contract research organization backed by AmorChem, has completed a management buyout (MBO). NuChem management, consisting of Marc LeBel, Daniel Guay, Marc Janes and John Mancuso, acquired 95 percent of AmorChem's voting shares. Terms weren't released for the deal, which was funded by Investissement Québec and Fonds de Transfert d’Entreprises du Québec. NuChem, a specialist in medicinal and synthetic chemistry services, launched in 2011 with the support of AmorChem, a Canadian early-stage life sciences venture capital firm. It helped develop several of AmorChem's projects with Québec research centres.
3 min read · 22 February 2019
San Francisco-based DoorDash, an on-demand food service, has raised $400 million in Series F funding, according to a blog post on its site. Temasek and Dragoneer Investment Group led the round with participation from return backers Softbank Vision Fund, DST Global, Coatue Management, GIC, Sequoia Capital and Y Combinator.
1 min read · 22 February 2019
Satellogic, a geospatial analytics company, has appointed Rick Dunn as its new chief financial officer. Previously, Dunn was CFO of PowerTeam Services. Satellogic's backers include Tencent, CrunchFund and Pitanga.
3 min read · 22 February 2019
Portland, Oregon and Cypress, California-based Circle Media Labs, a provider of screen time management and parental control solutions to families, has raised $20 million in Series B funding. The investors included NETGEAR, T-Mobile US, Third Kind Venture Capital and Relay Ventures.
1 min read · 22 February 2019
Baanto International Ltd, a Toronto-based developer of touch sensing solutions, has raised an undisclosed financing from Canadian intellectual-property lender Quantius. Founded in 2009, Baanto makes products that incorporate elements of its ShadowSense touchscreen technology for a range of applications, including educational and boardroom solutions, digital signage and military applications. Led by CEO Avanindra Utukuri, the company will use the funds raised for its global growth strategy. In 2014, Baanto secured $6 million in financing led by Canadian specialty finance firm Difference Capital Financial.
2 min read · 21 February 2019
